' // 'TESTEEEEEEEEEEEEEEEEEEE 22' ; return x; } function AbreJanela( Texto ){ // window.alert( Texto ); Janela=window.open("","Janelinha","height=200,width=400,scrollbars=yes,status=yes,left=150,screenX=150,top=150,screenY=150,resizable=yes,titlebar=yes"); Janela.document.write("
CÓDIGO | Assuntos | DEDALUS | Produção (BDPI) | Teses (BDDT) | FAPESP | ASSUNTOS | |
---|---|---|---|---|---|---|---|
CB381.8.11.1.4 | ANTIPIRÉTICOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.1.5 | HIPNOANALGÉSICOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.1.6 | HIPNÓTICOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.1.7 | SEDATIVOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.2 | ESTIMULANTES DO SISTEMA NERVOSO CENTRAL |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.2X | ANALÉPTICOS ver ESTIMULANTES DO SISTEMA NERVOSO CENTRAL |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.3 | FÁRMACOS PSICOTRÓPICOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.3.1 | ALUCINOGÊNICOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.3.2 | ANSIOLÍTICOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.3.2X | TRANQUILIZANTES ver ANSIOLÍTICOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.3.3 | ANTIDEPRESSIVOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.3.3X | MEDICAMENTOS ANTIDEPRESSIVOS ver ANTIDEPRESSIVOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.3.4 | ANTIPSICÓTICOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.3.4X | NEUROLÉPTICOS ver ANTIPSICÓTICOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.3.4X | MEDICAMENTO NEUROLÉPTICO ver ANTIPSICÓTICOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.3X | AGENTES PSICOATIVOS ver FÁRMACOS PSICOTRÓPICOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.3X | PSICOFÁRMACOS ver FÁRMACOS PSICOTRÓPICOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.3X | PSICOTRÓPICOS ver FÁRMACOS PSICOTRÓPICOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.4 | NEUROTRANSMISSORES |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.4.1 | AGENTES DOPAMINÉRGICOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.4.1X | AGENTES DOPAMÍNICOS ver AGENTES DOPAMINÉRGICOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.4.1X | AGONISTAS DE DOPAMINA ver AGENTES DOPAMINÉRGICOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11.4X | NEURORREGULADORES ver NEUROTRANSMISSORES |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.11X | AGENTES DE AÇÃO NO SISTEMA NERVOSO CENTRAL ver FÁRMACOS (SISTEMA NERVOSO CENTRAL) |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.12 | FÁRMACOS (SISTEMA NERVOSO PERIFÉRICO) |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.12.1 | ADRENÉRGICOS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.12.1.1 | ESTIMULANTES |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.12.1.2 | ANTAGONISTAS |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.12.1.2.1 | BETA-BLOQUEADORES |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
CB381.8.12.1.2.2 | ALFA-BLOQUEADORES |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Próx. Página | Menu | Pesquisar no DEDALUS | Macroestrutura |